HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

Can AI crack pharma's drug repurposing goldmine?

With AI now capable of analyzing decades' worth of data, FDA is pushing pharma to leverage its "enormous, untapped value" by repurposing drugs.

By PharmaVoice · May 29, 2026 · via PharmaVoice
Can AI crack pharma's drug repurposing goldmine?

Image: PharmaVoice

This is an aggregated industry headline. Read the full story at PharmaVoice →

Tags
theweekformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
ASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
The WeekFiercePharma ↗
ASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
Although the first-in-class PD-1xVEGF bispecific didn't disappoint on its overall survival headline message, d…
Jun 1, 2026
ASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
The WeekFierceBiotech ↗
ASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
Although the first-in-class PD-1xVEGF bispecific didn't disappoint on its overall survival headline message, d…
Jun 1, 2026
AARP data show U.S. drug prices rise postlaunch as foreign prices fall
The WeekBriefing
AARP data show U.S. drug prices rise postlaunch as foreign prices fall
AARP found top U.S. brand-name drugs climbed 81% in list price since launch while prices abroad fell 13%, hint…
Jun 1, 2026